Just a quick question out of the blue.
Does anyone understand the current craze going on with many of the biotech companies these days? Little revenue, no earnings on most of them, but promises of possibly billion dollar markets. Many of these biotechs have been rewarded with muiltibillion dollar market caps on promise alone. Many of these companies won't be profitable for years.
Cree on the other hand, huge earnings, huge margins, even more huge promises of new products with even huger (is ther such a word?) multibillion markets.
We are told that Mr. Market is rarely wrong, and never wrong in the long term. What are we to make of the fact of the incredible multiples in the DNA-based biotechs compared with the recent abuse piled on my poor Cree that has a great business NOW, and huge potential markets being addressed only months away.
The more I compare Cree with other equities, the better it looks in every way, except the market can't sell Cree fast enough the past 6 months. Oh well, just idle thoughts today... |
